Ginwa Enterprise (Group) Inc. (SHA:600080)
5.70
-0.15 (-2.56%)
May 21, 2026, 3:00 PM CST
Ginwa Enterprise (Group) Revenue
Ginwa Enterprise (Group) had revenue of 126.94M CNY in the quarter ending March 31, 2026, with 18.28% growth. This brings the company's revenue in the last twelve months to 563.66M, down -2.31% year-over-year. In the year 2025, Ginwa Enterprise (Group) had annual revenue of 544.04M, down -7.07%.
Revenue (ttm)
563.66M
Revenue Growth
-2.31%
P/S Ratio
3.57
Revenue / Employee
958.60K
Employees
588
Market Cap
2.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 544.04M | -41.42M | -7.07% |
| Dec 31, 2024 | 585.46M | 20.06M | 3.55% |
| Dec 31, 2023 | 565.40M | -13.97M | -2.41% |
| Dec 31, 2022 | 579.37M | 45.34M | 8.49% |
| Dec 31, 2021 | 534.04M | -134.14M | -20.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Enwei Pharmaceutical | 879.60M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 843.87M |
| Hainan Huluwa Pharmaceutical Group | 710.14M |
| Chengdu huasun technology group Inc. , LTD. | 527.86M |
| Zhejiang Shapuaisi Pharmaceutical | 459.57M |
| Anhui Huangshan Capsule | 437.17M |
| Guhan Pharmaceutical Group | 344.12M |
| Qinghai Spring Medicinal Resources Technology | 303.67M |